What is the treatment for abnormal copper levels?

Treatment of Abnormal Copper Levels

For Copper Overload (Wilson's Disease)

Lifelong chelation therapy with D-penicillamine or trientine is the cornerstone of treatment for Wilson's disease, with zinc acetate serving as maintenance therapy once copper levels are controlled. 1, 2

Initial Treatment for Symptomatic Patients

• D-penicillamine is the first-line chelation therapy, starting at 250-500 mg/day initially and increasing to a maintenance dose of 750-1500 mg/day (or 20 mg/kg/day in children, rounded to nearest 250 mg) divided into 2-3 doses taken 1 hour before meals 1, 2
• Supplemental pyridoxine (25-50 mg/day) must be provided with D-penicillamine since it interferes with pyridoxine action 1
• Trientine is the alternative chelator when D-penicillamine is not tolerated or causes adverse effects 1
• Tetrathiomolybdate at 120 mg/day divided into 6 doses of 20 mg each is an emerging option for copper reduction, particularly when standard chelation is unsuitable 3

Critical Warning About Neurologic Worsening

• Neurologic symptoms may paradoxically worsen during the first month of penicillamine therapy, but the drug should NOT be withdrawn as discontinuation increases the risk of developing sensitivity reactions upon resumption 2
• If neurologic deterioration continues beyond one month, consider short courses of dimercaprol (BAL) while continuing penicillamine 2

Maintenance Therapy

• Zinc acetate (50 mg elemental zinc three times daily) is the preferred maintenance treatment once initial chelation has stabilized the patient, as it blocks intestinal copper absorption by inducing metallothionein production in enterocytes 4
• Zinc must be taken separated from food and beverages (except water) by at least one hour to ensure adequate absorption 4

Monitoring Treatment Efficacy

• Measure 24-hour urinary copper excretion, which should be highest immediately after starting treatment (may exceed 1000 μg/24 hours initially) 1
• For adequately treated patients, free serum copper (non-ceruloplasmin bound copper) should be less than 10 μg/dL 5
• Monitor 24-hour urinary copper excretion every 6-12 months to assess ongoing treatment efficacy 5

Dietary Copper Restriction

• Daily diet must contain no more than 1-2 mg of copper, excluding chocolate, nuts, shellfish, mushrooms, liver, molasses, broccoli, and copper-enriched cereals 2
• Use distilled or demineralized water if drinking water contains more than 0.1 mg/L of copper 2

---

For Copper Deficiency

For severe copper deficiency with neurological symptoms, immediate intravenous copper replacement at 4-8 mg/day is essential, as delays can result in permanent neurological damage. 6

Severity-Based Treatment Algorithm

• Mild deficiency: Initiate oral supplementation with 1-2 mg copper daily for 3 months, then recheck levels 6
• Severe deficiency (plasma copper <8 μmol/L or <50 μg/dL): Urgent specialist referral for intravenous copper replacement at 4-8 mg/day (4-8 times standard nutritional recommendations) 6
• If oral supplementation fails to improve copper levels after 3 months, refer for intravenous copper injections 6

Critical Pre-Treatment Assessment

• Always measure both zinc AND copper levels simultaneously before initiating replacement therapy, as zinc excess is a common cause of copper deficiency and these minerals compete for intestinal absorption 6
• Measure C-reactive protein (CRP) alongside copper levels to differentiate true deficiency from inflammatory conditions that falsely alter ceruloplasmin 6
• Measure serum copper, ceruloplasmin, and 24-hour urinary copper to confirm diagnosis 6

Zinc-Copper Balance

• Maintain a zinc-to-copper ratio of 8:1 to 15:1 when supplementing either mineral to prevent competitive inhibition of absorption 6
• High-dose zinc supplementation (>30 mg daily) can paradoxically cause copper deficiency and requires careful monitoring 6
• Close monitoring is mandatory if higher doses of either zinc or copper are indicated 6

High-Risk Populations Requiring Screening

• Post-bariatric surgery patients (especially Roux-en-Y gastric bypass) require copper level monitoring every 6-12 months indefinitely, as they are at particularly high risk for copper deficiency 6, 7, 8
• Patients on long-term parenteral nutrition require copper monitoring every 6-12 months 6
• Patients with jejunostomy tubes on home enteral nutrition, major burn patients, and those on continuous renal replacement therapy >2 weeks require regular monitoring 6

Neurological Complications

• Neurological manifestations of copper deficiency (myelopathy, ataxia, peripheral neuropathy) may be irreversible if treatment is delayed, unlike hematological disturbances which typically correct with supplementation 7, 9, 8
• Intravenous copper repletion results in rapid correction of hematologic abnormalities (anemia, neutropenia, leukopenia) but only partial resolution of neurologic deficits even with aggressive treatment 8